Aster Launched Perpetual Contract Linked to Oura Health IPO
The platform introduced a new trading vehicle allowing users to bet on Oura Health's market valuation.
Updated on Sept. 23, 2026 in Healthcare

Live Poll
Do you trust decentralized platforms that allow leveraged speculation on pre-IPO company valuations?
Aster has launched an OURA/USD1 perpetual futures contract, providing crypto-native traders with exposure to the upcoming Oura Health IPO. The contract allows for 20x leverage and uses the USD1 stablecoin for settlement.
Why it matters
These perpetual contracts grant non-accredited crypto traders access to price action for high-profile companies, a market segment traditionally restricted to institutional investors.
Oura Health is planning an IPO of 50 million shares with a target valuation of up to $15.6 billion. The new Aster perpetual contract offers 20x leverage and tracks the market-implied share price.
The players
Aster
Aster is a trading platform that enables crypto-native users to access perpetual futures contracts for pre-IPO companies.
Oura Health
Oura Health is a Finnish technology company known for developing smart rings that track sleep and health metrics.
Nasdaq
Nasdaq is a global stock exchange that serves as the intended listing venue for Oura Health's upcoming initial public offering.
The details
The contract is designed to track market sentiment regarding Oura Health's valuation without granting actual equity ownership in the company. Oura Health, based in Finland, recently began its roadshow as it pursues a listing on the Nasdaq exchange.
Timeline
September 21, 2026: Oura Health began its IPO roadshow.
September 23, 2026: Aster launched the OURA/USD1 perpetual contract.
December 31, 2026: The Aster USD1 RWA Boost rewards campaign ends.
Market Landscape
This move continues the trend of synthetic asset exposure for non-accredited investors, mirroring Aster's previous pre-IPO perpetuals for SpaceX and OpenAI. It expands the reach of crypto-native trading platforms into traditional equity market valuations.
Investors using the Aster platform should note that the perpetual contract does not provide actual ownership and carries high risk due to 20x leverage. Traders participating in the rewards campaign should monitor the December 31, 2026 deadline for any changes to their portfolio.
The takeaway
While these contracts allow retail participants to speculate on major IPO valuations, they carry significant financial risks distinct from traditional stock ownership. Investors should ensure they understand the leverage mechanics and the nature of the underlying stablecoin assets before participating.
Further reading
For broader trends in industry-specific investment products, see our Healthcare section.
Live Poll
Do you trust decentralized platforms that allow leveraged speculation on pre-IPO company valuations?










